// App-Quantinova.ai

3530.0 : Exploitation of treatment induced tumor lysis to enhance sensitivity of ctDNA analysis: A first-in-human pilot study.

Researchers

Presenter

  • Daniel Adam Breadner

Principal Investigators

  • Rohann Jonathan Mark Correa

  • Morgan Black

  • Andrew Warner

  • Melody Qu

  • Diane Logan

  • Michael Susmoy Sanatani

  • Jawaid Younus

  • Brian P Yaremko

  • George Rodrigues

  • Phillip S. Blanchette

  • Joanna Laba

  • Vasudeva Bhat

  • Clive D. Morris

  • Emma Green

  • Greg Jones

  • Alison L Allan

  • David A. Palma

  • Jacques Raphael

Medical Centers

  • London Regional Cancer Centre, London, ON, Canada

  • London Health Sciences Center, London, ON, Canada

  • Department of Oncology, Division of Medical Oncology, Schulich School of Medicine & Dentistry, Western University and London Regional Cancer Program, London, ON, Canada

  • 800 Commissioners Road East, London, ON,...

  • LHSC London Regional Cancer Program, London, ON, Canada

  • London Regional Cancer Program, University of Western Ontario, London, ON, Canada

  • Department of Radiation Oncology, London Regional Cancer Program, London, ON, Canada

  • Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada

  • Inivata, Cheshire, United Kingdom

  • Inivata, Cambridge, United Kingdom

  • Inivata, Cambridge, United Kingdom

  • London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada

  • London Regional Cancer Program, Western University, London, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

  • First-In-Human

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved